Finding 1227758 (2025-001)

Material Weakness Repeat Finding
Requirement
I
Questioned Costs
-
Year
2025
Accepted
2026-08-25

AI Summary

  • Core Issue: The Society failed to keep proper documentation showing that vendor evaluations for suspension and debarment were completed before contracts were signed.
  • Impacted Requirements: This finding relates to compliance with 2 CFR §200.214 and 2 CFR Part 180, which require internal controls to prevent transactions with suspended or debarred parties.
  • Recommended Follow-Up: The Society should improve its documentation practices to ensure timely retention of vendor evaluation records to mitigate risks of noncompliance.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security Assistance Listing Number: 93.318 Federal Award Identification Number and Year: NU3HCK000011/2021 Award Period: 1/1/2025 – 12/31/2025 Type of Finding: Significant Deficiency in Internal Control over Compliance Criteria or specific requirement: In accordance with 2 CFR §200.214 and 2 CFR Part 180, nonfederal entities are prohibited from entering into covered transactions with suspended or debarred parties. The OMB Compliance Supplement requires the entity to establish and maintain internal controls to ensure compliance with suspension and debarment requirements. Condition: During testing, we noted the Society performed suspension and debarment evaluations on vendors (e.g., SAM.gov verification), however did not retain documentation demonstrating that these vendor evaluations were completed prior to contract execution. Questioned costs: None. Context: Documentation reviewed lacked sufficient date and time stamping to evidence when the evaluation was performed. This condition was identified for all items tested; however, we independently verified that the vendors selected were not suspended or debarred. Cause: The Society did not maintain adequate documentation to support that suspension and debarment procedures were performed timely. Effect: Although no instances of noncompliance were identified, the lack of documented evidence supporting the timely performance of suspension and debarment procedures increases the risk that the Society could enter into transactions with ineligible parties. Repeat Finding: This is not a repeat finding. Recommendation: We recommend the Society enhance controls to ensure adequate documentation is retained to support the procedures are performed timely with respect to vendor evaluation for suspension or debarment. Views of responsible officials: There is no disagreement with the audit finding. Management has developed a corrective action plan to address the matter identified which is presented in the accompanying Corrective Action Plan.

Corrective Action Plan

U.S. Department of Health and Human Services American Society for Microbiology (the Society) respectfully submits the following corrective action plan for the year ended December 31, 2025. Audit period: January 1 – December 31, 2025 The findings from the schedule of findings and questioned costs are discussed below. The findings are numbered consistently with the numbers assigned in the schedule. FINDINGS—FEDERAL AWARD PROGRAMS AUDITS U.S. Department of Health and Human Services 2025-001 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security – Assistance Listing No. 93.318 Recommendation: We recommend the Society enhance controls to ensure adequate documentation is retained to support the procedures are performed timely with respect to vendor evaluation for suspension or debarment. Explanation of disagreement with audit finding: There is no disagreement with the audit finding. Action taken in response to finding: Management has updated the internal procurement process documentation to include specific preparer and reviewer sign offs required to demonstrate the date that suspension and debarment checks were completed. Name(s) of the contact person(s) responsible for corrective action: Sharon Oluga Planned completion date for corrective action plan: 07/31/2026 If the U.S. Department of Health and Human Services has questions regarding this plan, please call Sharon Oluga at 202-942-9284.

Categories

Procurement, Suspension & Debarment

Programs in Audit

ALN Program Name Expenditures
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $3.71M
93.318 PROTECTING AND IMPROVING HEALTH GLOBALLY: BUILDING AND STRENGTHENING PUBLIC HEALTH IMPACT, SYSTEMS, CAPACITY AND SECURITY $1.39M
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $224,828
98.001 USAID FOREIGN ASSISTANCE FOR PROGRAMS OVERSEAS $170,183
47.074 BIOLOGICAL SCIENCES $20,473